Is radiofrequency ablation (RFA) still a tool in the box? Current application.

Andris Veiss; Maija Radzina

Abstract

Background / Objective
Radiofrequency ablation (RFA) continues to be a significant tool in the medical field, especially for its minimally invasive nature and broad range of applications. RFA has been utilized in some form for about 70-80 years, with significant advancements over the last 40 years. It is one of several ablative therapies used to treat various medical conditions, particularly tumors. Each modality has its strengths and weaknesses, and the choice of treatment depends on factors such as tumor size, location, patient health, and specific clinical goals.

Methods
-
Results
-

Conclusions
RFA is well-established, cost-effective, and suitable for a variety of tumor types but can be limited by tissue impedance and cooling effects from blood flow.

Original language	English
Pages	16
Number of pages	1
Publication status	Published - 18 Oct 2024
Externally published	Yes
Event	9th Baltic Congress of Radiology - Riga , Latvia Duration: 17 Oct 2024 → 19 Oct 2024 https://bcr2024.lv/bcr-2024-posters/

Congress

Congress	9th Baltic Congress of Radiology
Abbreviated title	BCR2024
Country/Territory	Latvia
City	Riga
Period	17/10/24 → 19/10/24
Internet address	https://bcr2024.lv/bcr-2024-posters/

Field of Science*

3.2 Clinical medicine

Publication Type*

3.4. Other publications in conference proceedings (including local)

Access to Document

IS RADIOFREQUENCY ABLATIONFinal published version, 2.09 MB

Cite this

@conference{8555eec8ea61465c95ecec153992353b,

title = "Is radiofrequency ablation (RFA) still a tool in the box? Current application.",

abstract = "Background / ObjectiveRadiofrequency ablation (RFA) continues to be a significant tool in the medical field, especially for its minimally invasive nature and broad range of applications. RFA has been utilized in some form for about 70-80 years, with significant advancements over the last 40 years. It is one of several ablative therapies used to treat various medical conditions, particularly tumors. Each modality has its strengths and weaknesses, and the choice of treatment depends on factors such as tumor size, location, patient health, and specific clinical goals.Methods-Results-ConclusionsRFA is well-established, cost-effective, and suitable for a variety of tumor types but can be limited by tissue impedance and cooling effects from blood flow.",

author = "Andris Veiss and Maija Radzina",

year = "2024",

month = oct,

day = "18",

language = "English",

pages = "16",

note = "9th Baltic Congress of Radiology, BCR2024 ; Conference date: 17-10-2024 Through 19-10-2024",

url = "https://bcr2024.lv/bcr-2024-posters/",

}

TY - CONF

T1 - Is radiofrequency ablation (RFA) still a tool in the box? Current application.

AU - Veiss, Andris

AU - Radzina, Maija

PY - 2024/10/18

Y1 - 2024/10/18

N2 - Background / ObjectiveRadiofrequency ablation (RFA) continues to be a significant tool in the medical field, especially for its minimally invasive nature and broad range of applications. RFA has been utilized in some form for about 70-80 years, with significant advancements over the last 40 years. It is one of several ablative therapies used to treat various medical conditions, particularly tumors. Each modality has its strengths and weaknesses, and the choice of treatment depends on factors such as tumor size, location, patient health, and specific clinical goals.Methods-Results-ConclusionsRFA is well-established, cost-effective, and suitable for a variety of tumor types but can be limited by tissue impedance and cooling effects from blood flow.

AB - Background / ObjectiveRadiofrequency ablation (RFA) continues to be a significant tool in the medical field, especially for its minimally invasive nature and broad range of applications. RFA has been utilized in some form for about 70-80 years, with significant advancements over the last 40 years. It is one of several ablative therapies used to treat various medical conditions, particularly tumors. Each modality has its strengths and weaknesses, and the choice of treatment depends on factors such as tumor size, location, patient health, and specific clinical goals.Methods-Results-ConclusionsRFA is well-established, cost-effective, and suitable for a variety of tumor types but can be limited by tissue impedance and cooling effects from blood flow.

UR - https://bcr2024.lv/abstract-book/

M3 - Abstract

SP - 16

T2 - 9th Baltic Congress of Radiology

Y2 - 17 October 2024 through 19 October 2024

ER -